(Q40909516)

24 September 2017

1 reference

title

CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia (English)

1 reference

24 September 2017

0 references

0 references

Hudson CJ

1

1 reference

24 September 2017

Young LT

series ordinal

2

1 reference

24 September 2017

Li PP

series ordinal

3

1 reference

24 September 2017

Warsh JJ

series ordinal

4

1 reference

24 September 2017

1 March 1993

1 reference

24 September 2017

1 reference

24 September 2017

13

1 reference

24 September 2017

278-293

1 reference

24 September 2017

3

1 reference

Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Inositol trisphosphate and diacylglycerol as second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Receptor-effector coupling by G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Increased platelet intracellular calcium concentration in patients with bipolar affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Genetics, immunology, and virology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Blunted beta-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Isoproterenol dose-response studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Reduced cyclic AMP production in the blood platelets from schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Prostaglandin receptor sensitivity in psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Fetal neural development and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Normalization of blunted lymphocyte beta-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Beta-adrenergic receptor function in affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890130311

21 January 2018

Identifiers

DOI

10.1002/SYN.890130311

1 reference

24 September 2017

1 reference